This is the first report to show that sulindac sulfide activates both NF-κB and AP-1 transcription factors, which may be important in NSAID-induced gastrointestinal toxicity [53-56] and the increased risk of acute myocardial infarction in patients receiving some NSAIDs [57]. The gene discussed is JUN; the disease is myocardial infarction.